Discover the promising results of selpercatinib, a kinase inhibitor by Eli Lilly, in treating RET-mutant medullary thyroid cancer. Outperforms competitors with improved outcomes and longer progression-free survival.
Discover the groundbreaking findings on how intense exercise could slow down the progression of Parkinson's disease. Learn about the neuroprotective effects and potential non-drug therapeutic targets.
Discover the groundbreaking findings on how intense exercise could slow down the progression of Parkinson's disease. Learn about the neuroprotective effects and potential non-drug therapeutic targets.
Discover the promising results of selpercatinib, a kinase inhibitor by Eli Lilly, in treating RET-mutant medullary thyroid cancer. Outperforms competitors with improved outcomes and longer progression-free survival.